What is Wave Life Sciences's net investment in lease?

Wave Life Sciences (WVE) reported net investment in lease of $10.99M in Q1 2026.

How has Wave Life Sciences's net investment in lease changed year-over-year?

Wave Life Sciences's net investment in lease decreased by 33.7% year-over-year, from $16.58M to $10.99M.

What is the long-term trend for Wave Life Sciences's net investment in lease?

Over 5 years (2020 to 2025), Wave Life Sciences's net investment in lease has grown at a -5.2% compound annual growth rate (CAGR), from $16.23M to $12.46M.

Wave Life Sciences WVE Net Investment in Lease

Net Investment in Lease at other companies

Sarepta Therapeutics, Inc.SRPT

——

Ionis PharmaceuticalsIONS

——

Madrigal Pharmaceuticals, Inc.MDGL

——

ALN

Alnylam PharmaceuticalsALNY

——

Beam TherapeuticsBEAM

——

Dyne Therapeutics, Inc.DYN

——

Other financials

Income statement

See full

Revenue$38.2M+317%

Operating income-$31.3M+37.2%

Net income-$26.1M+44.4%

EPS (diluted)-$0.13+55.2%

Balance sheet

See full

Cash & equivalents$544.6M+124%

Total debt$15.7M-33.4%

Total equity$511.7M+198%

Total assets$583.5M+102%

Cash flow

See full

Operating cash flow-$59.6M+5.5%

CapEx$438.0K+165%

Free cash flow-$60.0M+5.1%

Valuation

See full

Market cap$1.14B+13.0%

Enterprise value$615.92M-22.3%

P/S15.1×-12.2×

Profitability

See full

Operating margin-75.7%-33.6pp

Net margin-66.5%-29.9pp

FCF margin-27.2%-12.6pp

Returns & leverage

See full

Return on equity-53.7%—

Debt / equity0×-0.1×

Current ratio11.3×+8.3×

Where this comes from

Reported directly by Wave Life Sciences in its filing.

Tagged under the XBRL concept us-gaap:OperatingLeaseRightOfUseAsset.

The official record: Wave Life Sciences’s 10-Q, filed April 28, 2026, on SEC EDGAR. View the filing →

Ask your AI about Wave Life Sciences's net investment in lease.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Wave Life Sciences's net investment in lease?: Wave Life Sciences (WVE) reported net investment in lease of $10.99M in Q1 2026.
How has Wave Life Sciences's net investment in lease changed year-over-year?: Wave Life Sciences's net investment in lease decreased by 33.7% year-over-year, from $16.58M to $10.99M.
What is the long-term trend for Wave Life Sciences's net investment in lease?: Over 5 years (2020 to 2025), Wave Life Sciences's net investment in lease has grown at a -5.2% compound annual growth rate (CAGR), from $16.23M to $12.46M.